Mosliciguat is under clinical development by Bayer and currently in Phase I for Kidney Disease (Nephropathy). According to GlobalData, Phase I drugs for Kidney Disease (Nephropathy) have a 71% phase ...

Treprostinil is under clinical development by United Therapeutics and currently in Phase III for Idiopathic Pulmonary Fibrosis.

In the era of DOACs, risk for CTEPH following pulmonary embolism is affected by multiple factors, including gender and heart load.

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

The following is a summary of “Relevance of patient-centered actigraphy measures in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a qualitative interview study,” ...

Pulmonary angiography, specifically the computed tomographic version, is the gold standard for diagnosing lung embolism.

Nearly one in five people in the UK are believed to suffer from chronic inflammation – but there are ways to reduce it There’s an important distinction to be made between acute inflammation ...

She also reported chronic ... severe pulmonary hypertension. The pulmonary arteries are markedly enlarged and a large, organized filling defect consistent with chronic thromboembolism of the ...

Echocardiography, however, may yield additional prognostic information in higher risk patients and can aid in distinguishing acute from chronic RV dysfunction ... 18 Additionally, while less reliable ...

7. Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121:877 905 This huge, comprehensive ...

Intensive blood pressure (BP) control in youth with chronic kidney disease (CKD) slows progression, delaying the need for kidney replacement therapy (KRT). Most youth with CKD have hypertension and BP ...

Right heart failure is the most common cause of mortality in patients with pulmonary arterial hypertension.1 This includes chronic thromboembolic pulmonary hypertension (CTEPH), which through ...